As Tilray Expands Its Medical Cannabis Business, Should You Buy, Sell, or Hold TLRY Stock?

Tilray’s (TLRY) aggressive expansion into Germany’s medical cannabis scene signals a drive to claim more of the global spotlight. The company posted fiscal 2025 highlights that include $821 million in …